Drug intelligence / Profile preview

Sinupret

Development stage
Unknown
Lead developer
Bionorica
Modality
Small Molecules
Administration
Oral
01

Overview

Sinupret is a standardized phytotherapeutic product developed by Bionorica SE, composed of a specific combination of five herbal ingredients: gentian root (Gentiana lutea), primrose flowers (Primula veris), sorrel herb (Rumex acetosa), elder flowers (Sambucus nigra), and vervain herb (Verbena officinalis). It is primarily indicated for the treatment of acute and chronic rhinosinusitis. The drug exerts a multi-target effect, including secretolytic activity by stimulating chloride secretion via the cystic fibrosis transmembrane conductance regulator (CFTR), anti-inflammatory action through the inhibition of cyclooxygenase-2 and 5-lipoxygenase, and broad-spectrum antiviral activity against common respiratory viruses. It is widely utilized in Europe and Asia (marketed as 欧龙马 in China) as an evidence-based herbal treatment for respiratory congestion and inflammation.

Brand names
Sinupret欧龙马OulongmaSinupret forteSinupret extract
Other names
Bionorica SinupretSinupret oral dropsSinupret syrup
02

Targets

ANO1 (Anoctamin-1)

Beyond the preview

Go deeper on Sinupret.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinupret.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call